Please login to the form below
Britain
This page shows the latest Britain news and features for those working in and with pharma, biotech and healthcare.
GSK reveals plans for £400m R&D facility expansion in England
We are excited to find a development partner to realise our vision to foster the next generation of world-class scientists and biotechnology firms in Britain,” he added.
Latest news
-
British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
According to The Times, Britain’s secretary of state for business, energy and industrial strategy Kwasi Kwarteng has asked officials to monitor the deal to ‘better understand’ PMI’s plans for
-
COVID-19 booster dose programme planned for September launch in Britain
Preparations have begun for a COVID-19 booster dose programme in Britain, following new interim advice from the Joint Committee on Vaccination and Immunisation (JCVI).
-
UK government ‘concerned’ over Elliott Management’s plans for GSK
According to The Times, Britain’s Secretary of State for Business, Energy and Industrial Strategy is believed to have asked government officials to back GSK’s chief executive officer Emma Walmsley –
-
UK orders 40 million additional doses of Valneva’s COVID-19 vaccine
Valneva’s chief executive officer Thomas Lingelbach also said that the COVID-19 vaccine, known as VLA2001, could be made available in Britain between July and September.
-
Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
Vaccine could be in use in Britain by September. Valneva is set to begin manufacturing doses of its COVID-19 vaccine for commercial use at its site in Livingston, Scotland, according ... The French-headquartered company’s chief executive officer Thomas
British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
COVID-19 booster dose programme planned for September launch in Britain
UK government ‘concerned’ over Elliott Management’s plans for GSK
UK orders 40 million additional doses of Valneva’s COVID-19 vaccine
Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
More from news
Approximately 3 fully matching, plus 250 partially matching documents found.
Latest Intelligence
-
Setting up for success in a post-Brexit, post-pandemic Britain
Creating a new biotech affiliate and seeking marketing authorisation for a new drug in the UK during a pandemic
-
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
With a recent PwC poll showing that more than 20 of Britain’s biggest firms have no plans for employees to come back to the office, the need to evolve employee
-
Pharma funding and M&A in 2020
So in 2020, as much as investors will be paying attention to noises from Boston, the San Francisco Bay Area, Britain, yes Britain, and even Brussels, I suspect they’ll also
-
The transatlantic opioid crisis
Meanwhile, in Britain. A Public Health England enquiry revealed the scale of opioid consumption in the UK in September 2019, with prescriptions now being handed out to one in eight of
-
25 Women Leaders in UK Healthcare (part 2)
She became Britain’s youngest hospital leader when she was appointed chief executive of Birmingham Children’s Hospital in 2007 at the age of 32, subsequently helping it win Provider Trust
Setting up for success in a post-Brexit, post-pandemic Britain
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pharma funding and M&A in 2020
The transatlantic opioid crisis
25 Women Leaders in UK Healthcare (part 2)
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest appointments
-
UCB appoints new managing director of Britain and Ireland
Steve Turley joins from Lundbeck
-
Gopa Mitra retires from PAGB
She steps down after 34 years at organisation. Gopa Mitra is to retire from the Proprietary Association of Great Britain (PAGB) after 34 years at the organisation.
-
GSK's Lawson elected PAGB president
The Proprietary Association of Great Britain (PAGB), which represents OTC companies in the UK, has elected Carlton Lawson of GlaxoSmithKline (GSK) as its new president.
-
MHRA announces senior appointment
McGuire's career has also seen him involved with a number of professional bodies, including the Association of Anaesthetists of Great Britain and Ireland, the Royal College of Anaesthetists and the
-
Steve Arnold joins UCB from Gilead
Appointed managing director for the British and Irish Isles. UCB has appointed Steve Arnold as managing director for Great Britain and Ireland.
UCB appoints new managing director of Britain and Ireland
Gopa Mitra retires from PAGB
GSK's Lawson elected PAGB president
MHRA announces senior appointment
Steve Arnold joins UCB from Gilead
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
IWD2021: #ChooseToChallenge Interview with Dennis O’Brien, Lucid Group CEO
I learnt so much from Melanie Lee, who was Director of R&D at Celltech, Britain’s most successful biotech.
-
Let's be ambitious for patients and life sciences investment in Global Britain
In post-Brexit ‘Global Britain’, Government wants a rejuvenated MHRA to help the UK become a global early launch market. ... sciences investment for the new Global Britain.
-
HOW INNOVATION IS RESHAPING THE NORTH EAST LIFE SCIENCES LANDSCAPE
In a post Brexit Britain where the UK’s future trading relationship with the EU remains uncertain, adopting more innovative business practices will be crucial to keeping the sector globally competitive. ... We must ensure the North East’s
-
The fight against COVID-19 needs to have diversity at the heart of its strategy
In recognition of this, the #CharitySoWhite campaign has demanded action over the disproportionate impact of the virus on Britain’s minorities.
-
Hanover Communications
Let's be ambitious for patients and life sciences investment in Global Britain.
Let's be ambitious for patients and life sciences investment in Global Britain
The fight against COVID-19 needs to have diversity at the heart of its strategy
Hanover Communications
More from PMHub
Approximately 0 fully matching, plus 23 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
-
Digital strategist
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- GSK reveals plans for £400m R&D facility expansion in England
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med
- British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Merck & Co's cancer drug Keytruda gaining traction in US
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
